Aptose Biosciences Inc. Annual report [Section 13 and 15(d), not S-K Item 405]

Annual report [Section 13 and 15(d), not S-K Item 405]

Note 6 - Property and Equipment, Net

Note 6 - Property and Equipment, Net

12 Months Ended

Dec. 31, 2024

Notes to Financial Statements

Property and equipment

Property and equipment, net

Property and equipment, net consists of the following:


December 31, 2024	Cost		Accumulated depreciation		Net book value
Laboratory equipment	$	—	$	—	$	—
Computer hardware		33		29		4
Computer software		222		222		—
Office furniture		118		117		1
Leasehold improvements		171		150		21
Total	$	544	$	518	$	26

December 31, 2023	Cost		Accumulated depreciation		Net book value
Laboratory equipment	$	197	$	87	$	110
Computer hardware		29		25		4
Computer software		222		222		—
Office furniture		140		132		8
Leasehold improvements		213		183		30
Total	$	801	$	649	$	152

Depreciation expense for the years ended December 31, 2024 and 2023 were $32 thousand and $88 thousand, respectively.

During the year ended December 31, 2024, the Company recorded a loss on disposition of fixed assets of $76 thousand, with these assets having had an original cost of $262 thousand and accumulated depreciation of

$164 thousand. There was no loss on disposal of fixed assets in the year ended December 31, 2023. For the years ended December 31, 2024 and 2023, the Company had additions to fixed assets of $5 thousand and $29 thousand, respectively.